Viewing Study NCT06891833


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2025-12-31 @ 2:34 PM
Study NCT ID: NCT06891833
Status: RECRUITING
Last Update Posted: 2025-10-02
First Post: 2025-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of BL-M07D1 With or Without Pertuzumab Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module